Colorectal cancer (CRC) stands as the second most common cause of cancer-related mortality globally and p53, a widely recognized tumor suppressor, contributes to the development of CRC.

Research from the University of California, Irvine has revealed how disruption of the circadian clock, the body's internal, ...

Learn about colorectal cancer, its risk factors, symptoms, and the latest treatment options. Early detection through ...

Merck said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed a late-stage trial ...

A new, comprehensive study has uncovered critical insights into the genetic makeup of colorectal cancer (CRC), providing a ...

Factors related to sex and gender can affect therapy outcomes and should not be overlooked in clinical practice or research.

An attempt by Merck & Co. to unlock the microsatellite stable (MSS) metastatic colorectal cancer market has ended in failure.

Circadian disruption and gut microbiome changes are linked to accelerating colorectal cancer progression, highlighting a crucial connection between lifestyle and health.

Dr. Cynthia Yoshida with UVA Cancer Center’s Colorectal Cancer Screening Program explains the rise in cancer cases among ...

A team of researchers from the First Hospital of Hebei Medical University in China has uncovered intriguing evidence that ...

Aug. 14, 2024 — A new study has identified diet-derived molecules called metabolites as main drivers of young-onset colorectal cancer risk, especially those associated with red and processed meat.

Research from the University of California, Irvine has revealed how disruption of the circadian clock, the body's internal, ...